NASDAQ:DOMH Dominari (DOMH) Stock Price, News & Analysis $3.23 -0.01 (-0.31%) Closing price 05/21/2026 04:00 PM EasternExtended Trading$3.22 -0.01 (-0.43%) As of 05/21/2026 07:12 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Dominari Stock (NASDAQ:DOMH) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Dominari alerts:Sign Up Key Stats Today's Range$3.11▼$3.2550-Day Range$2.75▼$3.9252-Week Range$2.68▼$8.40Volume39,097 shsAverage Volume191,680 shsMarket Capitalization$73.03 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingSell Company Overview Dominari Holdings Inc., a biotechnology company, focuses on developing small-molecule anticancer therapeutics. The company's pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small molecule treatment for acute myeloid leukemia and acute lymphoblastic leukemia. The company is also developing an antiviral platform that inhibits replication of viruses, including influenza virus, Ebolavirus and Marburg virus, SARS-CoV, MERS-CoV, and SARS-CoV-2. It has license agreements with the University of Texas, Silo Pharma Inc., and Wake Forest University Health Sciences. The company was formerly known as AIkido Pharma Inc. and changed its name to Dominari Holdings Inc. in December 2022. Dominari Holdings Inc. was founded in 1967 and is headquartered in New York, New York. Read More Dominari Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks6th Percentile Overall ScoreDOMH MarketRank™: Dominari scored higher than 6% of companies evaluated by MarketBeat, and ranked 837th out of 858 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion0.5 / 5Analyst RatingSell Consensus RatingDominari has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.Amount of Analyst CoverageDominari has received no research coverage in the past 90 days.Read more about Dominari's stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Dominari is -0.80, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Dominari is -0.80, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioDominari has a P/B Ratio of 2.31. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Short Interest4.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted4.76% of the float of Dominari has been sold short.Short Interest Ratio / Days to CoverDominari has a short interest ratio ("days to cover") of 5.42.Change versus previous monthShort interest in Dominari has recently decreased by 19.19%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldDominari does not currently pay a dividend.Dividend GrowthDominari does not have a long track record of dividend growth. News and Social Media0.6 / 5News Sentiment0.00 News Coverage This WeekMarketBeat has tracked 2 news articles for Dominari this week, compared to 1 article on an average week.Search Interest14 people have searched for DOMH on MarketBeat in the last 30 days. Company Ownership1.2 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Dominari insiders have not sold or bought any company stock.Percentage Held by Insiders55.30% of the stock of Dominari is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions42.48% of the stock of Dominari is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Dominari's insider trading history. Receive DOMH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Dominari and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. DOMH Stock News HeadlinesDominari (NASDAQ:DOMH) Stock Rating Upgraded by Wall Street ZenMay 16, 2026 | americanbankingnews.comDominari Holdings Congratulates Cerebras Systems on "Blockbuster" Initial Public OfferingMay 15, 2026 | prnewswire.comThe chokepoint supplier behind SpaceX's $1.75 trillion empireWhen Musk laughed and said 'you need transformers to run transformers,' it wasn't a joke - it was a confession. The world's largest supercomputer requires power equipment that takes 120 weeks to build, and Musk built Colossus in just 122 days. One small American company is positioned to close that gap faster than anyone else, yet Wall Street still prices it like an afterthought. Dylan Jovine has the full story and the ticker. | Behind the Markets (Ad)Dominari Holdings Issues Shareholder LetterMay 13, 2026 | prnewswire.comDominari Q1 Revenue Increases by 395% Over Q1 2025May 13, 2026 | prnewswire.comDominari Holdings Announces Record Date for Cash DividendMay 4, 2026 | prnewswire.comDominari 2025 Revenue Surges 487% in 2025, Balance Sheet Strengthens SignificantlyMarch 31, 2026 | prnewswire.comDominari Releases Letter to Shareholders and ClientsMarch 16, 2026 | prnewswire.comSee More Headlines DOMH Stock Analysis - Frequently Asked Questions How have DOMH shares performed this year? Dominari's stock was trading at $4.95 at the beginning of the year. Since then, DOMH stock has decreased by 34.7% and is now trading at $3.23. How were Dominari's earnings last quarter? Dominari Holdings Inc. (NASDAQ:DOMH) posted its quarterly earnings results on Monday, August, 11th. The company reported ($1.02) earnings per share for the quarter. The company earned $34.10 million during the quarter. Dominari had a negative trailing twelve-month return on equity of 206.20% and a negative net margin of 31.37%. Who are Dominari's major shareholders? Dominari's top institutional investors include Renaissance Technologies LLC (0.59%) and PFG Investments LLC (0.06%). Insiders that own company stock include Christopher Franklin Devall and Kyle Michael Wool. View institutional ownership trends. How do I buy shares of Dominari? Shares of DOMH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Dominari own? Based on aggregate information from My MarketBeat watchlists, some other companies that Dominari investors own include Avino Silver & Gold Mines (ASM), Crescent Point Energy (CPG), Kroger (KR), KraneShares CSI China Internet ETF (KWEB) and MSP Recovery (LIFW). Company Calendar Last Earnings8/11/2025Record date for 5/29 Dividend5/15/2026Ex-Dividend for 5/29 Dividend5/15/2026Today5/21/2026Dividend Payable5/29/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Yellow Zone (3m+) 1-Year History May 25 Aug 25 Nov 25 Feb 26 May 26 DOMH's financial health is in the Yellow zone, according to TradeSmith. DOMH has been in this zone for over 3 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MED - DRUGS Sub-IndustryBiotechnology Current SymbolNASDAQ:DOMH Previous SymbolNASDAQ:DOMH CIK12239 WebN/A Phone(112) 745-1374Fax703-992-9348Employees4Year FoundedN/AProfitability EPS (Trailing Twelve Months)($4.03) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$22.43 million Net Margins-31.37% Pretax Margin-16.67% Return on Equity-206.20% Return on Assets-155.26% Debt Debt-to-Equity RatioN/A Current Ratio1.41 Quick Ratio1.41 Sales & Book Value Annual Sales$123.10 million Price / Sales0.59 Cash FlowN/A Price / Cash FlowN/A Book Value$1.40 per share Price / Book2.31Miscellaneous Outstanding Shares22,610,000Free Float10,108,000Market Cap$73.03 million OptionableNot Optionable Beta0.69 Options Trading Made Easy - Download NowLearn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.Get This Free Report This page (NASDAQ:DOMH) was last updated on 5/22/2026 by MarketBeat.com Staff. From Our PartnersSystem failure: The strongest leverage for gold…$9 trillion in U.S. debt must be refinanced in 2026 - at current rates - while the largest foreign buyers of T...Golden Portfolio | SponsoredSatellite Images Spot Potential $10 Trillion Discovery'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...Altimetry | SponsoredI had never heard of this 1888 accountAn investment account dating back to 1888 has quietly delivered average annual returns of 29% over the last 25...The Oxford Club | Sponsored"Computers are about to become obsolete" - George Gilder. Here’s why.George Gilder predicted the iPhone 16 years early, called Netflix a decade before it dominated streaming, and ...Eagle Publishing | SponsoredTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredSpaceX controls two-thirds of all satellites - and it is about to go publicSpaceX is targeting an IPO on June 11th, with trading set to begin June 12th and the roadshow kicking off June...NXT Wave Research | SponsoredHow to Profit from Elon’s AI lab before it goes publicElon Musk's AI lab has partnered with the Department of Defense, Oracle, and Palantir - and he just filed conf...InvestorPlace | SponsoredYour $29.97 book is free todayWhy Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...Profits Run | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Dominari Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Dominari With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
